{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:27:13Z","timestamp":1793827633382,"version":"4.6.1"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","funder":[{"name":"Innovative Drug Research and Development-National Science and Technology Major Project","award":["2025ZD1803400"],"award-info":[{"award-number":["2025ZD1803400"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:p>Glypican-3 (GPC3) is highly expressed in hepatocellular carcinoma. A 72-year-old man with hepatitis B-related cirrhosis and rising alpha-fetoprotein had a small hepatic nodule on gadoxetic acid-enhanced MRI (EOB-MRI). The nodule enlarged on 3 consecutive EOB-MRI examinations during a 5-month follow-up but remained indeterminate for hepatocellular carcinoma. GPC3-targeted PET\/MR showed intense uptake in the lesion and no extrahepatic disease, and hepatectomy confirmed moderately differentiated hepatocellular carcinoma with strong GPC3 expression. This case suggests the potential value of GPC3-targeted PET\/MR for clarifying MRI-indeterminate early hepatocellular carcinoma.<\/jats:p>","DOI":"10.1097\/rlu.0000000000006695","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:00:20Z","timestamp":1789124420000},"page":"1111-1112","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Glypican-3-Targeted PET\/MR Identifies MRI-Indeterminate Early Hepatocellular Carcinoma in Cirrhosis"],"prefix":"10.1097","volume":"51","author":[{"given":"Wenzhu","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology"},{"name":"Hubei Province Key Laboratory of Molecular Imaging"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology"},{"name":"Hubei Province Key Laboratory of Molecular Imaging"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology"},{"name":"Hubei Province Key Laboratory of Molecular Imaging"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7263-7399","authenticated-orcid":false,"given":"Xiaoli","family":"Lan","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology"},{"name":"Hubei Province Key Laboratory of Molecular Imaging"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"R1-20261104","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0016-5085(03)00689-9","article-title":"Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma","volume":"125","author":"Capurro","year":"2003","journal-title":"Gastroenterology"},{"key":"R2-20261104","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/modpathol.2008.85","article-title":"Utility and limitations of glypican-3 expression for the diagnosis of hepatocellular carcinoma at both ends of the differentiation spectrum","volume":"21","author":"Shafizadeh","year":"2008","journal-title":"Mod Pathol"},{"key":"R3-20261104","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1158\/1078-0432.CCR-25-1856","article-title":"Glypican-3\u2013targeted PET imaging for precise diagnosis of hepatocellular carcinoma: from bench to bedside","volume":"32","author":"Lin","year":"2026","journal-title":"Clin Cancer Res"},{"key":"R4-20261104","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2967\/jnumed.124.268147","article-title":"[68Ga] Ga-RAYZ-8009: a glypican-3\u2013targeted diagnostic radiopharmaceutical for hepatocellular carcinoma molecular imaging\u2014a first-in-human case series","volume":"65","author":"Poot","year":"2024","journal-title":"J Nucl Med"},{"key":"R5-20261104","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"R6-20261104","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1148\/radiol.2018181494","article-title":"Liver Imaging Reporting and Data System (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients","volume":"289","author":"Chernyak","year":"2018","journal-title":"Radiology"},{"key":"R7-20261104","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jhep.2017.12.014","article-title":"Comparison of the accuracy of AASLD and LI-RADS criteria for the non-invasive diagnosis of hepatocellular carcinoma smaller than 3 cm","volume":"68","author":"Ronot","year":"2018","journal-title":"J Hepatol"},{"key":"R8-20261104","doi-asserted-by":"crossref","first-page":"e314","DOI":"10.1259\/bjr\/27727228","article-title":"Small (\u2264 2 cm) hepatocellular carcinoma in patients with chronic liver disease: comparison of gadoxetic acid-enhanced 3.0 T MRI and multiphasic 64-multirow detector CT","volume":"85","author":"Hwang","year":"2012","journal-title":"Br J Radiol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000006695","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:00:41Z","timestamp":1793826041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000006695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":8,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006695","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"2026-07-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}